226 related articles for article (PubMed ID: 11874692)
1. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
Pinilla L; Barreiro ML; Gonzalez LC; Tena-Sempere M; Aguilar E
J Endocrinol; 2002 Mar; 172(3):441-8. PubMed ID: 11874692
[TBL] [Abstract][Full Text] [Related]
2. Oestrogenic effects of neonatal administration of raloxifene on hypothalamic-pituitary-gonadal axis in male and female rats.
Pinilla L; González LC; Gaytán F; Tena-Sempere M; Aguilar E
Reproduction; 2001 Jun; 121(6):915-24. PubMed ID: 11373178
[TBL] [Abstract][Full Text] [Related]
3. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
4. Neonatal exposure to SERMs disrupts neuroendocrine development and postnatal reproductive function through alteration of hypothalamic kisspeptin neurons in female rats.
Ichimura R; Takahashi M; Morikawa T; Inoue K; Kuwata K; Usuda K; Yokosuka M; Watanabe G; Yoshida M
Neurotoxicology; 2016 Sep; 56():64-75. PubMed ID: 27395752
[TBL] [Abstract][Full Text] [Related]
5. Anatomically-specific actions of oestrogen receptor in the developing female rat brain: effects of oestradiol and selective oestrogen receptor modulators on progestin receptor expression.
Gonzales KL; Quadros-Mennella P; Tetel MJ; Wagner CK
J Neuroendocrinol; 2012 Feb; 24(2):285-91. PubMed ID: 21981076
[TBL] [Abstract][Full Text] [Related]
6. Influence of oestrogenic compounds on monoamine transporters in rat striatum.
Le Saux M; Di Paolo T
J Neuroendocrinol; 2006 Jan; 18(1):25-32. PubMed ID: 16451217
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for altered reproductive function in female rats following neonatal administration of raloxifene.
Tena-Sempere M; Barreiro ML; Aguilar E; Pinilla L
Eur J Endocrinol; 2004 Mar; 150(3):397-403. PubMed ID: 15012627
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat.
Sánchez-Criado JE; Guelmes P; Bellido C; Gónzalez M; Hernández G; Aguilar R; Garrido-Gracia JC; Bello AR; Alonso R
Neuroendocrinology; 2002 Oct; 76(4):203-13. PubMed ID: 12411737
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats.
Wu X; Glinn MA; Ostrowski NL; Su Y; Ni B; Cole HW; Bryant HU; Paul SM
Brain Res; 1999 Nov; 847(1):98-104. PubMed ID: 10564741
[TBL] [Abstract][Full Text] [Related]
11. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro.
Nuttall ME; Fisher PW; Suva LJ; Gowen M
Eur J Cancer; 2000 Sep; 36 Suppl 4():S63-4. PubMed ID: 11056323
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
Lamb CA; Helguero LA; Fabris V; Lucas C; Molinolo AA; Lanari C
Breast Cancer Res Treat; 2003 May; 79(1):25-35. PubMed ID: 12779079
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of fluid reabsorption in the efferent ducts of the rat by testosterone propionate, 17beta-oestradiol 3-benzoate, flutamide and tamoxifen.
Hansen LA; Clulow J; Jones RC
Int J Androl; 1997 Oct; 20(5):265-73. PubMed ID: 16130270
[TBL] [Abstract][Full Text] [Related]
14. Gonadotrope oestrogen receptor-alpha and -beta and progesterone receptor immunoreactivity after ovariectomy and exposure to oestradiol benzoate, tamoxifen or raloxifene in the rat: correlation with LH secretion.
Sánchez-Criado JE; de Las Mulas JM; Bellido C; Aguilar R; Garrido-Gracia JC
J Endocrinol; 2005 Jan; 184(1):59-68. PubMed ID: 15642783
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic Effects of Tamoxifen on Oestrogen Regulation of Luteinising Hormone and Prolactin Secretion in Female Rats.
Aquino NS; Araujo-Lopes R; Batista IA; Henriques PC; Poletini MO; Franci CR; Reis AM; Szawka RE
J Neuroendocrinol; 2016 Jan; 28(1):. PubMed ID: 26563816
[TBL] [Abstract][Full Text] [Related]
16. Differential responses of hypothalamic LHRH-I and -II to castration and gonadal steroid or tamoxifen treatment in cockerels.
Wilson SC; Gladwell RT; Cunningham FJ
J Endocrinol; 1990 Apr; 125(1):139-46. PubMed ID: 2187047
[TBL] [Abstract][Full Text] [Related]
17. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
Birzniece V; Sutanto S; Ho KK
J Clin Endocrinol Metab; 2012 Apr; 97(4):E521-7. PubMed ID: 22319035
[TBL] [Abstract][Full Text] [Related]
18. Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.
Fernández-Suárez ME; Escolà-Gil JC; Pastor O; Dávalos A; Blanco-Vaca F; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
Sci Rep; 2016 Sep; 6():32105. PubMed ID: 27601313
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.
Miki Y; Suzuki T; Nagasaki S; Hata S; Akahira J; Sasano H
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):281-9. PubMed ID: 19429434
[TBL] [Abstract][Full Text] [Related]
20. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
